Skip to main content

Featured

Nerve Block Therapy Offers Hope for Migraine Sufferers

                           Calgary neurologist Dr. Serena Orr injecting a patient to help treat migraines.  Researchers in Calgary are spotlighting a promising treatment for people living with severe migraines: occipital nerve blocks . This approach involves injecting a small amount of anesthetic near the occipital nerves at the back of the head, which can interrupt pain signals and provide rapid relief. Neurologist Dr. Serena Orr of the University of Calgary has been at the forefront of this research, recommending updates to the American Headache Society’s guidelines for emergency departments. The new recommendations encourage doctors to consider nerve blocks as a frontline option for patients arriving with debilitating migraine attacks. Patients who have received the treatment report significant improvement. Some describe it as the first time they’ve been able to escape the crushing pain, nausea,...

article

Pharmacare in Canada: A Dream or a Reality?

 


The fate of Canada's pharmacare plan is uncertain as the federal government faces challenges in implementing a universal drug coverage program, even if a bill to create one passes in Parliament. Bill C-213, the Canada Pharmacare Act, aims to establish a national framework for pharmacare that would ensure all Canadians have access to prescription drugs based on their medical needs, not their ability to pay. 

However, the bill does not specify how the program would be funded, administered or negotiated with the provinces and territories, leaving many questions unanswered about the feasibility and cost-effectiveness of pharmacare. Some experts and stakeholders have expressed doubts about whether Ottawa has the political will, the constitutional authority and the fiscal capacity to deliver on its promise of pharmacare, especially in the wake of the COVID-19 pandemic that has strained the health care system and the public purse.

Comments